These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1366357)

  • 1. Patenting EPO analogs: screening vs. predictability.
    Kelly P
    Biotechnology (N Y); 1990 Feb; 8(2):112-3. PubMed ID: 1366357
    [No Abstract]   [Full Text] [Related]  

  • 2. Patent protection upheld in Amgen/Genetics Institute battle over EPO.
    Riley J; Pristave R
    Nephrol News Issues; 1991 Apr; 5(4):18-9. PubMed ID: 1961279
    [No Abstract]   [Full Text] [Related]  

  • 3. Patenting drug products: anticipating Hatch-Waxman issues during the claims drafting process.
    Mahn TG
    Food Drug Law J; 1999; 54(2):245-53. PubMed ID: 11758582
    [No Abstract]   [Full Text] [Related]  

  • 4. Patent watch.
    Harrison C
    Nat Rev Drug Discov; 2008 Nov; 7(11):882-3. PubMed ID: 18974746
    [No Abstract]   [Full Text] [Related]  

  • 5. Biotech Patenting--EuroLegal Conference. 26-27 February 2003, London, UK.
    Pereira N
    IDrugs; 2003 Apr; 6(4):340-4. PubMed ID: 12839015
    [No Abstract]   [Full Text] [Related]  

  • 6. EPO patient dispute: court battle ends at the start.
    Gershon D
    Nature; 1989 Dec 21-28; 342(6252):846. PubMed ID: 2594071
    [No Abstract]   [Full Text] [Related]  

  • 7. ACOG Committee Opinion. Number 364 May 2007. Patents, medicine, and the interests of patients.
    Committees on Ethics and Genetics of American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2007 May; 109(5):1249-54. PubMed ID: 17470613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First round to Amgen in EPO battle.
    Robertson D
    Nat Biotechnol; 2000 May; 18(5):483. PubMed ID: 10802602
    [No Abstract]   [Full Text] [Related]  

  • 9. Building the proper foundation for genomics-based patents.
    Chahine KG
    Nat Biotechnol; 1998 Jul; 16(7):683-5. PubMed ID: 9661205
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotech patent dispute. EPO licensing talks break down.
    Gershon D
    Nature; 1990 Feb; 343(6258):500. PubMed ID: 2300198
    [No Abstract]   [Full Text] [Related]  

  • 11. Erythropoietin in the UK: a setback for gene patents?
    Crespi RS
    Nat Biotechnol; 2005 Mar; 23(3):367-8. PubMed ID: 15765090
    [No Abstract]   [Full Text] [Related]  

  • 12. Patent strategies in molecular diversity.
    Green GD
    Mol Divers; 1997-1998; 3(4):247-52. PubMed ID: 9850521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use patents, carve-outs, and incentives--a new battle in the drug-patent wars.
    Rai A
    N Engl J Med; 2012 Aug; 367(6):491-3. PubMed ID: 22873529
    [No Abstract]   [Full Text] [Related]  

  • 14. "Ganske" threatens biotechnology patents worldwide.
    Glaser V
    Nat Biotechnol; 1997 Feb; 15(2):121. PubMed ID: 9035128
    [No Abstract]   [Full Text] [Related]  

  • 15. Patents: a threat to innovation?
    Manocaran M
    Science; 2010 Jan; 327(5961):31-2; author reply 32. PubMed ID: 20044557
    [No Abstract]   [Full Text] [Related]  

  • 16. How Patent Troll Legislation Can Increase Timely Access to Generic Drugs.
    Treasure CL; Kesselheim AS
    JAMA Intern Med; 2016 Jun; 176(6):729-30. PubMed ID: 27183456
    [No Abstract]   [Full Text] [Related]  

  • 17. [Requirements for use and patenting of drugs in the United States of America].
    Ferrario V
    Farmaco Prat; 1972 Jun; 27(6):305-17. PubMed ID: 5032930
    [No Abstract]   [Full Text] [Related]  

  • 18. Reach-through claims for drug target patents: Rx for pharmaceutical policy.
    Bohrer RA
    Nat Biotechnol; 2008 Jan; 26(1):55-6. PubMed ID: 18183015
    [No Abstract]   [Full Text] [Related]  

  • 19. Patent watch: EPO rejects reach through claims.
    Nat Rev Drug Discov; 2010 Jan; 9(1):12. PubMed ID: 20043023
    [No Abstract]   [Full Text] [Related]  

  • 20. The application of the patent laws to the drug approval process.
    Coggio BD; Cerrito FD
    Food Drug Law J; 1997; 52(4):345-55. PubMed ID: 10346669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.